SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-20-007773
Filing Date
2020-04-15
Accepted
2020-04-15 16:32:59
Documents
8
Period of Report
2020-05-26
Effectiveness Date
2020-04-15

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A nby20200407_def14a.htm DEF 14A 592594
2 a1.jpg GRAPHIC 1124
3 a01.jpg GRAPHIC 230992
4 a02.jpg GRAPHIC 177844
5 graphic01.jpg GRAPHIC 16111
6 nby20200401_pre14aimg001.gif GRAPHIC 3999
7 nby20200401_pre14aimg002.jpg GRAPHIC 6187
8 sig1.jpg GRAPHIC 7968
  Complete submission text file 0001437749-20-007773.txt   1206037
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 20794074
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences